Hint mode is switched on Switch off

Ascentage Pharma Group International, ordinary share
6855, KYG0519B1023

Add a stock to WL
Choose all Reset all
Ascentage Pharma Group International, сountry — China
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Issuer

Profile
Ascentage Pharma Group International operates as a clinical-stage biotechnology company. The Company develops novel therapies for cancers, hepatitis B virus, age-related diseases, and more. Ascentage Pharma Group International conducts businesses in China, the United States, and ...
Ascentage Pharma Group International operates as a clinical-stage biotechnology company. The Company develops novel therapies for cancers, hepatitis B virus, age-related diseases, and more. Ascentage Pharma Group International conducts businesses in China, the United States, and other countries.
Show more Hide

IFRS/US GAAP reports

2025
IV q eng
2024
IV q eng
Show all Hide

Indicators

News

07/02/2025 Ascentage Pharma Says Underwriters Exercise Option to Buy Additional American Depositary Shares
30/01/2025 Ascentage Pharma Group International Raised $126 Million from US IPO of Over 7 Million ADS
28/01/2025 Ascentage Pharma Closes IPO of 7.33 Million American Depositary Shares
30/12/2024 Ascentage Pharma Group International Files for Proposed US IPO
All organization news

Other stocks and deposit receipts

Holders

Industry Leaders

Registration is required to get access.